Master Framework For Relapse or Refractory Acute Myeloid Leukemia | MicrobiomeTrials← Back to trialsNCT06459024
Master Framework For Relapse or Refractory Acute Myeloid Leukemia
RecruitingOBSERVATIONAL
Trial Details
Start: 2024-06-28Est. Completion: 2032-07
Enrollment target: 4,000 participants Locations- University Hospital Aachen, Aachen, Germany
- University Hospital Greifswald, Greifswald, Germany
- University Hospital Halle, Halle, Germany
- University Hospital of Rostock, Rostock, Germany
- Policlinico Sant'Orsola-Malpighi, Bologna, BO, Italy
- Ospedale "A. Perrino", Brindisi, BR, Italy
- ASST Spedali Civili, Brescia, BS, Italy
- Azienda Ospedaliera S. Croce e Carle, Cuneo, CN, Italy
- Ospedale Valduce, Como, CO, Italy
- ASST Cremona, Cremona, CR, Italy
- AOU Universitaria Arcispedale Sant'Anna, Ferrara, FE, Italy
- IRCCS Ospedale Policlinico San Martino, Genova, GE, Italy
- Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan, MI, Italy
- ASST Grande Ospedale Metropolitano Niguarda, Milan, MI, Italy
- Azienda Ospedaliera Ospedali Riuniti Villa Sofia - Cervello, Palermo, PA, Italy
- Presidio Ospedaliero "Santo Spirito", Pescara, PE, Italy
- Ospedale Santa Maria della Misericordia, Perugia, PG, Italy
- Ospedale Santa Maria delle Croci, Ravenna, RA, Italy
- Fondazione Policlinico Tor Vergata, Roma, RM, Italy
- Policlinico Umberto I, Roma, RM, Italy
- Policlinico Universitario Fondazione Agostino Gemelli, Roma, RM, Italy
- Ospedale Sant'Andrea, Roma, RM, Italy
- Ospedale infermi di Rimini, Rimini, RN, Italy
- AOU San Giovanni di Dio e Ruggi d'Aragona, Salerno, SA, Italy
- AOU Città della Salute e della Scienza di Torino, Torino, TO, Italy
- AO Ordine Mauriziano, Torino, TO, Italy
- IOV Istituto Oncologico Veneto, Castelfranco Veneto, TV, Italy
- ASST Valle Olona, Busto Arsizio, VA, Italy
- AOU Careggi, Florence, Italy
- IRST Istituto Romagnolo per lo Studio dei Tumori Dino Amadori, Meldola, Italy
Other microbiome trials you might be interested in
Acute Myeloid LeukemiaRelapse/Recurrence
This is a multicenter, randomized, open-label, pragmatic low intervention clinical trial comparing high intensity reindu…
Brno, CzechiaEst. completion Jan 2028
Myeloid Leukemia
To learn the recommended dose of momelotinib that can be given in combination with gilteritinib to participants with AML…
Houston, United StatesEst. completion Oct 1, 2027
Azienda Ospedaliera di Rilievo Nazionale Antonio Cardarelli, Naples, ItalyAOU Maggiore della Carità, Novara, ItalyAzienda Ospedale-Università Padova, Padova, ItalyOspedale San Bortolo, Vicenza, ItalyThe Hospital of Lithuanian University of Health Sciences Kauno Klinikos, Kaunas, LithuaniaUniversity Clinical Center in Gdańsk, Gdansk, PolandFundeni Clinical Institute, Bucharest, RomaniaUniversity Hospital La Fe, Valencia, SpainPhase 1
Recruiting
Recurrent Acute Myeloid LeukemiaRefractory Acute Myeloid Leukemia
This phase I/II trial studies the best dose of sorafenib when given together with busulfan and fludarabine in treating p…
Houston, United StatesEst. completion Dec 31, 2027